CancerTYPE ID in the Clinic

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.
July 17, 2018

Explaining Treatment Regimens to Patients with HR+/HER2–Metastatic Breast Cancer

Dr Thomas Bachelot is careful to set reasonable expectations for his patients with HR+/HER2–metastatic breast cancer regarding how long their treatment will last and how it will impact them.

October 1, 2014

Defining the Role of Pharmacists in Polycythemia Vera

Atheer Kaddis presents the role of the pharmacist with regards to polycythemia vera and describes why it is unique.Supported through funding from Incyte